Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions

Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions

US Patent 8889709 · Granted Nov 18, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors2025
Inhibitors2025
1,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compoun2025
1,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compoun2025
1,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compoun2025
Inhibitors of meprin α and β2025
Inhibitors of meprin α and β2025
Inhibitors of meprin α and β2025
Crystalline pharmaceutically acceptable salt and polymorphic form of the glutami2025
Humanized and de-immunized antibodies2024
Humanized and de-immunized antibodies2024
Inhibitors of bacterial glutaminyl cyclases for use in the treatment of periodon2024